Latest allergic asthma Stories
HØRSHOLM, Denmark, June 9, 2014 /PRNewswire/ -- First sublingual allergy immunotherapy tablet with robust results in allergic rhinitis and allergic asthma.
Reprogramming asthma-promoting immune cells in mice diminishes airway damage and inflammation, and could potentially lead to new treatments for people with asthma, researchers have found.
Allergic asthma affects more than 100 million people worldwide and its prevalence is increasing on average by 50% every decade! A study suggests that widely used antibiotics may be the cause for the increased incidences and severity of allergic asthma in children.
- A woman chauffeur.
- A woman who operates an automobile.